{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:08:26Z","timestamp":1777522106113,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SB\/YS\/LS3-66\/2013"],"award-info":[{"award-number":["SB\/YS\/LS3-66\/2013"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["6242-P52\/RGCB\/PMD\/DBT\/RPKT\/2015"],"award-info":[{"award-number":["6242-P52\/RGCB\/PMD\/DBT\/RPKT\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["RGNF-2012-13-ST-ORI-30084"],"award-info":[{"award-number":["RGNF-2012-13-ST-ORI-30084"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010803","name":"Department of Biotechnology, Government of West Bengal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006144","name":"Kerala State Council for Science, Technology and Environment","doi-asserted-by":"publisher","award":["015\/YIPB\/KBC\/2013\/CSTE"],"award-info":[{"award-number":["015\/YIPB\/KBC\/2013\/CSTE"]}],"id":[{"id":"10.13039\/501100006144","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005049","name":"Science and Engineering Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006143","name":"Department of Science and Technology, Government of Kerala","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015728","name":"Central University of Kerala","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ab.2019.113568","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T16:38:57Z","timestamp":1577205537000},"page":"113568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Semi-quantification of antibody-dependent enhancement (ADE) in the uptake of Adenovirus serotype 5 into THP-1 cells"],"prefix":"10.1016","volume":"591","author":[{"given":"Lathika","family":"Valliyott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjeet","family":"Dungdung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Pilankatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"39","key":"10.1016\/j.ab.2019.113568_bib1","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1016\/j.vaccine.2015.08.016","article-title":"Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71","volume":"33","author":"Zhang","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ab.2019.113568_bib2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/mt.2012.248","article-title":"Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus","volume":"21","author":"Zhou","year":"2013","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.ab.2019.113568_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00670-17","article-title":"Key role of the scavenger receptor MARCO in mediating adenovirus infection and subsequent innate responses of macrophages","volume":"8","author":"Maler","year":"2017","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.ab.2019.113568_bib4","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/JCM.41.11.5046-5052.2003","article-title":"Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors","volume":"41","author":"Sprangers","year":"2003","journal-title":"J. Clin. Microbiol."},{"issue":"7","key":"10.1016\/j.ab.2019.113568_bib5","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1128\/JVI.02864-12","article-title":"Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates","volume":"87","author":"Richardson","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ab.2019.113568_bib6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/1743-422X-8-506","article-title":"Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes","volume":"8","author":"Guan","year":"2011","journal-title":"Virol. J."},{"issue":"15","key":"10.1016\/j.ab.2019.113568_bib7","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2011.01.108","article-title":"A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.ab.2019.113568_bib8","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1016\/j.vaccine.2009.07.073","article-title":"An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity","volume":"27","author":"Khanam","year":"2009","journal-title":"Vaccine"},{"issue":"6869","key":"10.1016\/j.ab.2019.113568_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ab.2019.113568_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/21645515.2016.1238535","article-title":"Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: an open phase I\/II trial in healthy adults in Russia","volume":"13","author":"Dolzhikova","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"issue":"8","key":"10.1016\/j.ab.2019.113568_bib11","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/infdis\/jiy008","article-title":"Modification of the association between T-cell immune responses and human immunodeficiency virus type 1 infection risk by vaccine-induced antibody responses in the HVTN 505 trial","volume":"217","author":"Fong","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ab.2019.113568_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/13543776.18.3.293","article-title":"Adenovirus-vectored vaccines","volume":"18","author":"Chawla","year":"2008","journal-title":"Expert Opin. Ther. Pat."},{"issue":"11","key":"10.1016\/j.ab.2019.113568_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrmicro3360","article-title":"Novel vaccine vectors for HIV-1","volume":"12","author":"Barouch","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.ab.2019.113568_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1556\/EuJMI.1.2011.4.3","article-title":"Adenovirus-triggered innate signalling pathways","volume":"1","author":"Fejer","year":"2011","journal-title":"Eur. J. Microbiol. Immunol. (Bp)"},{"issue":"1","key":"10.1016\/j.ab.2019.113568_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/08830185.2013.823420","article-title":"Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection","volume":"33","author":"Chen","year":"2014","journal-title":"Int. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.ab.2019.113568_bib16","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1007\/s00705-017-3497-8","article-title":"A comparative review of viral entry and attachment during large and giant dsDNA virus infections","volume":"162","author":"Sobhy","year":"2017","journal-title":"Arch. Virol."},{"issue":"12","key":"10.1016\/j.ab.2019.113568_bib17","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/CVI.00316-10","article-title":"How innate immune mechanisms contribute to antibody-enhanced viral infections","volume":"17","author":"Ubol","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.ab.2019.113568_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/088282403763635465","article-title":"Antibody-dependent enhancement of virus infection and disease","volume":"16","author":"Tirado","year":"2003","journal-title":"Viral Immunol."},{"key":"10.1016\/j.ab.2019.113568_bib19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fimmu.2018.00597","article-title":"Modulation of dengue\/zika virus pathogenicity by antibody-dependent enhancement and strategies to protect against enhancement in Zika virus infection","volume":"9","author":"Khandia","year":"2018","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.ab.2019.113568_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001311","article-title":"Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand","volume":"5","author":"Anderson","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"5","key":"10.1016\/j.ab.2019.113568_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.chembiol.2010.04.010","article-title":"Quantitative cell-based reporter gene assays using droplet-based microfluidics","volume":"17","author":"Baret","year":"2010","journal-title":"Chem. Biol."},{"issue":"2","key":"10.1016\/j.ab.2019.113568_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4014\/jmb.1508.08007","article-title":"Cell-based assay design for high-content screening of drug candidates","volume":"26","author":"Nierode","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"issue":"4","key":"10.1016\/j.ab.2019.113568_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/1097-0320(20011201)45:4<237::AID-CYTO10024>3.0.CO;2-J","article-title":"Detection of a decrease in green fluorescent protein fluorescence for the monitoring of cell death: an assay amenable to high-throughput screening technologies","volume":"45","author":"Steff","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.ab.2019.113568_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-0799-1_3","article-title":"Quantification of GFP signals by fluorescent microscopy and flow cytometry","volume":"1163","author":"Wei","year":"2014","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.ab.2019.113568_bib25","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.14440\/jbm.2017.203","article-title":"Easy and low-cost stable positioning of suspension cells during live-cell imaging","volume":"4","author":"Ivanusic","year":"2017","journal-title":"J. Biol. Methods"},{"key":"10.1016\/j.ab.2019.113568_bib26","series-title":"Virology: A Laboratory Manual","first-page":"53","author":"Burleson","year":"1992"},{"issue":"3","key":"10.1016\/j.ab.2019.113568_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/jmv.21721","article-title":"The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines","volume":"82","author":"Pilankatta","year":"2010","journal-title":"J. Med. Virol."},{"issue":"Pt 1","key":"10.1016\/j.ab.2019.113568_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/mic.0.049601-0","article-title":"Pre-existing immunity against vaccine vectors--friend or foe?","volume":"159","author":"Saxena","year":"2013","journal-title":"Microbiology"},{"issue":"6","key":"10.1016\/j.ab.2019.113568_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr. Gene Ther."},{"issue":"4","key":"10.1016\/j.ab.2019.113568_bib30","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol. Ther."},{"issue":"23","key":"10.1016\/j.ab.2019.113568_bib31","doi-asserted-by":"crossref","first-page":"11833","DOI":"10.1128\/JVI.00857-06","article-title":"Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini","volume":"80","author":"Xie","year":"2006","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.ab.2019.113568_bib32","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1128\/JVI.79.19.12125-12131.2005","article-title":"Adenovirus receptors","volume":"79","author":"Zhang","year":"2005","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.ab.2019.113568_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.virusres.2009.02.010","article-title":"Adenovirus receptors and their implications in gene delivery","volume":"143","author":"Sharma","year":"2009","journal-title":"Virus Res."},{"issue":"5","key":"10.1016\/j.ab.2019.113568_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaf7643","article-title":"Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4(+) T cell responses that impair CD8(+) T cell function","volume":"1","author":"Larocca","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ab.2019.113568_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fimmu.2018.00335","article-title":"Seroprevalence of neutralizing antibodies against human adenovirus type-5 and chimpanzee adenovirus type-68 in cancer patients","volume":"9","author":"Zhao","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ab.2019.113568_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14712598.2015.993374","article-title":"Adenoviruses as gene\/vaccine delivery vectors: promises and pitfalls","volume":"15","author":"Appaiahgari","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ab.2019.113568_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1475-2875-11-209","article-title":"Immunogenicity when utilizing adenovirus serotype 4 and 5 vaccines expressing circumsporozoite protein in na\u00efve and adenovirus (Ad5) immune mice","volume":"11","author":"Schuldt","year":"2012","journal-title":"Malar. J."},{"issue":"9","key":"10.1016\/j.ab.2019.113568_bib38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2217\/fvl-2016-0070","article-title":"Simian adenoviruses as vaccine vectors","volume":"11","author":"Morris","year":"2016","journal-title":"Future Virol."},{"key":"10.1016\/j.ab.2019.113568_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2019.05.008","article-title":"A rapid strategy for constructing novel simian adenovirus vectors with high viral titer and expressing highly antigenic proteins applicable for vaccine development","volume":"268","author":"Luo","year":"2019","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.ab.2019.113568_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/mt.2015.194","article-title":"Development of novel adenoviral vectors to overcome challenges observed with HAdV-5-based constructs","volume":"24","author":"Alonso-Padilla","year":"2016","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.ab.2019.113568_bib41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2217\/fvl-2016-0070","article-title":"Simian adenoviruses as vaccine vectors","volume":"11","author":"Morris","year":"2016","journal-title":"Future Virol."},{"issue":"7","key":"10.1016\/j.ab.2019.113568_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ab.2019.113568_bib43","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/JVI.02950-14","article-title":"Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors","volume":"89","author":"Abbink","year":"2015","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.ab.2019.113568_bib44","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge","volume":"85","author":"Geisbert","year":"2011","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ab.2019.113568_bib45","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tim.2017.10.004","article-title":"A tale of two viruses: does heterologous Flavivirus immunity enhance Zika disease?","volume":"26","author":"Sariol","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ab.2019.113568_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fcimb.2018.00044","article-title":"Antibody-dependent enhancement and Zika: real threat or phantom menace?","volume":"8","author":"Mart\u00edn-Acebes","year":"2018","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.ab.2019.113568_bib47","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15252\/embr.201745302","article-title":"The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design","volume":"19","author":"Rey","year":"2018","journal-title":"EMBO Rep."},{"issue":"2","key":"10.1016\/j.ab.2019.113568_bib48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.virol.2011.08.026","article-title":"Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement","volume":"421","author":"Sun","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.ab.2019.113568_bib49","doi-asserted-by":"crossref","first-page":"22303","DOI":"10.1038\/srep22303","article-title":"Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.ab.2019.113568_bib50","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1016\/j.vaccine.2011.03.042","article-title":"Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China","volume":"29","author":"Sun","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ab.2019.113568_bib51","first-page":"e30","article-title":"Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China","volume":"3","author":"Wang","year":"2014","journal-title":"Emerg. Microb. Infect."},{"issue":"11","key":"10.1016\/j.ab.2019.113568_bib52","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.4049\/jimmunol.0804269","article-title":"Antiviral antibodies target adenovirus to phagolysosomes and amplify the innate immune response","volume":"182","author":"Zaiss","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.ab.2019.113568_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00670-17","article-title":"Key role of the scavenger receptor MARCO in mediating adenovirus infection and subsequent innate responses of macrophages","volume":"8","author":"Maler","year":"2017","journal-title":"mBio"}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000326971930819X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000326971930819X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:16:21Z","timestamp":1777392981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000326971930819X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":53,"alternative-id":["S000326971930819X"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2019.113568","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semi-quantification of antibody-dependent enhancement (ADE) in the uptake of Adenovirus serotype 5 into THP-1 cells","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2019.113568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113568"}}